TCWP’s ANI Pharmaceuticals ANIP Stock Holding History

TCWP’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25	Closed	–	–	336
2022 Q1	$0	Buy	+25	New	+$932	﹤0.01%	1716

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

TCWP's ANIP Position: Q2 2022 in Review

TCWP sold out of ANI Pharmaceuticals (ANIP) in Q2 2022, closing a stake of 25 shares.

TCWP first reported a position in ANIP in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 120 funds tracked by Wall St. Rank hold ANIP as of Q2 2022.

TCWP reported no remaining ANI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
TCWP sold 25 ANI Pharmaceuticals shares in Q2 2022.
TCWP first reported a position in ANI Pharmaceuticals in Q1 2022 and held it in 1 quarter.
TCWP's ANI Pharmaceuticals position peaked at $0 in Q1 2022.
120 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.